Zhejiang Ausun Pharmaceutical Co (SHSE:603229) EBIT per Share : ¥0.31 (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co EBIT per Share?

Zhejiang Ausun Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2025 was ¥0.16. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.31.

During the past 12 months, the average EBIT per Share Growth Rate of Zhejiang Ausun Pharmaceutical Co was -22.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 7.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 25.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zhejiang Ausun Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SHSE:603229' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -34.5 Med: 9.25 Max: 69.9
Current: 7.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Zhejiang Ausun Pharmaceutical Co was 69.90% per year. The lowest was -34.50% per year. And the median was 9.25% per year.

SHSE:603229's 3-Year EBIT Growth Rate is ranked worse than
51.01% of 1235 companies
in the Biotechnology industry
Industry Median: 8.1 vs SHSE:603229: 7.40

Zhejiang Ausun Pharmaceutical Co's EBIT for the three months ended in Mar. 2025 was ¥138.4 Mil.

Zhejiang Ausun Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co EBIT per Share Chart

Zhejiang Ausun Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.13

0.20

0.33

0.37

0.30

Zhejiang Ausun Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.16	0.10	0.07	-0.02	0.16

Zhejiang Ausun Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zhejiang Ausun Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	247.965	/	827.164
=	0.30

Zhejiang Ausun Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	138.432	/	851.423
=	0.16

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.31

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zhejiang Ausun Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Ausun Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016

Website

http://www.ausunpharm.com

Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Executives

Zheng Zhi Guo	Directors, senior managers
Zhang Hua Dong	Directors, senior managers
Liu Bing	Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines